or
forgot password

    • cancer clinical trials in concord, CA

    • Observational Evaluation of the Peristomal Skin Condition in Ostomates
    John Muir Health Concord Campus
    Concord, California 94520
    Ostomy
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    John Muir Medical Center-Concord Campus
    Concord, California 94520
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    Bay Area Cancer Research Dept.ofBayAreaCancerResearch
    Concord, California 94520
    CML
    Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
    John Muir Medical Center-Concord Campus

    Trial Locations
    John Muir Medical Center-Concord Campus
    John Muir Medical Center - Concord Campus
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Fatigue
    Talc in Treating Patients With Malignant Pleural Effusion
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Metastatic Cancer
    Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Sarcoma
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Breast Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Prostate Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Brain and Central Nervous System Tumors
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Pancreatic Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Anal Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Diarrhea, Radiation Enteritis
    Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Gastric Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Breast Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Lung Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Sarcoma
    Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Metastatic Cancer
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Lung Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Mount Diablo Medical Center
    Concord, California 94524-4110
    Carcinoma of Unknown Primary
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Bay Area Cancer Research Group
    Concord, California 94520
    Neoplasms, Diarrhea
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    Bay Area Cancer Research Group
    Concord, California 94520
    Breast Neoplasms, Breast Cancer, Metastasis
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma
    Bay Area Cancer Research Group
    Concord, California 94520
    Carcinoma, Renal Cell, Metastases, Neoplasm
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Bay Area Research Cancer Group
    Concord, California 94520
    Ovarian Neoplasms
    Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction, Sexuality and Reproductive Issues
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Mount Diablo Regional Cancer Center
    Concord, California 94524-4110
    Pancreatic Cancer
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Bay Area Cancer Research Group
    Concord, California 94520
    Non-Hodgkin's Lymphoma
    Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
    John Muir/Mount Diablo Cancer Center - Concord Campus
    Concord, California 94524-4110
    Lung Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Bay Area Cancer Research Group
    Concord, California 94520
    Non Small Cell Lung Carcinoma
    A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma
    Bay Area Cancer Research Group
    Concord, California 94520
    Renal Cell Carcinoma, Metastases
    Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
    Bay Area Cancer Research Group

    Trial Locations
    Bay Area Cancer Research Group
    East Bay Medical Oncology/Hematology Associates
    Carcinoma, Non-Small-Cell Lung
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Bay Area Cancer Research Group
    Concord, California 94520
    Multiple Myeloma
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Bay Area Cancer Research Group
    Concord, California 94520
    Myelodysplastic Syndrome, Iron Overload
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    Bay Medical Oncology & Hematology
    Concord, California 94520
    Diffuse Large-Cell Lymphoma
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Bay Area Cancer Research Group
    Concord, California 94520
    Carcinoma, Non-Small-Cell Lung
    Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
    Bay Area Cancer Research Group, LLC

    Trial Locations
    Bay Area Cancer Research Group, LLC
    East Bay Medical Oncology/Hematology Medical Associates
    Ovarian Neoplasms
    Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
    Bay Area Cancer Research Group
    Concord, California 94520
    Myelodysplastic Syndrome (MDS)
    Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
    Bay Area Cancer Research Dept.ofBayAreaCancerResearch
    Concord, California 94520
    Lymphoma, Mantle- Cell
    APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
    Bay Area Cancer Research Group, LLC
    Concord, California 94520
    Pancreatic Cancer, Metastatic Pancreatic Cancer
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
    Bay Area Cancer Research Group
    Concord, California 94520
    Transfusional Hemosiderosis
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Cancer Care Center at John Muir Health - Concord Campus
    Concord, California 94524-4110
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer